BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 10587706)

  • 1. De novo CD5+ Burkitt lymphoma/leukemia.
    Lin CW; O'Brien S; Faber J; Manshouri T; Romaguera J; Huh YO; Kantarjian H; Keating M; Albitar M
    Am J Clin Pathol; 1999 Dec; 112(6):828-35. PubMed ID: 10587706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma.
    Viswanatha DS; Foucar K; Berry BR; Gascoyne RD; Evans HL; Leith CP
    Mod Pathol; 2000 Jul; 13(7):825-33. PubMed ID: 10912944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burkitt transformation of mantle cell lymphoma.
    Felten CL; Stephenson CF; Ortiz RO; Hertzberg L
    Leuk Lymphoma; 2004 Oct; 45(10):2143-7. PubMed ID: 15370262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B Lymphoblastic Leukemia/Lymphoma With Burkitt-like Morphology and IGH/MYC Rearrangement: Report of 3 Cases in Adult Patients.
    Li Y; Gupta G; Molofsky A; Xie Y; Shihabi N; McCormick J; Jaffe ES
    Am J Surg Pathol; 2018 Feb; 42(2):269-276. PubMed ID: 29112016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow. A clinicopathologic study of 40 patients.
    Shapiro JL; Miller ML; Pohlman B; Mascha E; Fishleder AJ
    Am J Clin Pathol; 1999 Apr; 111(4):477-87. PubMed ID: 10191767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large cell variants of CD5+, CD23- B-cell lymphoma/leukemia.
    Dunphy CH; Perkins SL
    Arch Pathol Lab Med; 2001 Apr; 125(4):513-8. PubMed ID: 11260626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleolated variant of mantle cell lymphoma with leukemic manifestations mimicking prolymphocytic leukemia.
    Wong KF; So CC; Chan JK
    Am J Clin Pathol; 2002 Feb; 117(2):246-51. PubMed ID: 11865846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An aggressive case of Burkitt's lymphoma with t(8;14) and c-myc rearrangement transformed from CD5+ B-cell lymphoma.
    Niwano H; Aoki S; Tsukada N; Toba K; Fuse I; Kishi K; Koike T; Takahashi H; Yamamori S; Shibata A; Aizawa Y
    Ann Hematol; 1997; 75(5-6):221-5. PubMed ID: 9433379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD5 negative diffuse mantle cell lymphoma with splenomegaly and bone marrow involvement.
    Bell ND; King JA; Kusyk C; Nelson BP; Sendelbach KM
    South Med J; 1998 Jun; 91(6):584-7. PubMed ID: 9634125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of acute lymphoblastic leukemia with mature B-cell phenotype.
    Chan NP; Ma ES; Wan TS; Chan LC
    Leuk Res; 2003 Mar; 27(3):231-4. PubMed ID: 12537975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
    Lin P; Dickason TJ; Fayad LE; Lennon PA; Hu P; Garcia M; Routbort MJ; Miranda R; Wang X; Qiao W; Medeiros LJ
    Cancer; 2012 Mar; 118(6):1566-73. PubMed ID: 21882178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD5+ extranodal marginal zone B-cell (MALT) lymphoma. A low grade neoplasm with a propensity for bone marrow involvement and relapse.
    Ferry JA; Yang WI; Zukerberg LR; Wotherspoon AC; Arnold A; Harris NL
    Am J Clin Pathol; 1996 Jan; 105(1):31-7. PubMed ID: 8561085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathologic diagnosis and subtyping of lymphoma in bone marrow biopsies using histologic examination, immunohistochemistry and gene rearrangement studies].
    Xiao JC; Jin XL; Yuan F
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):120-4. PubMed ID: 15132847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mantle cell lymphoma in leukemic phase: characterization of its broad cytologic spectrum with emphasis on the importance of distinction from other chronic lymphoproliferative disorders.
    Wong KF; Chan JK; So JC; Yu PH
    Cancer; 1999 Sep; 86(5):850-7. PubMed ID: 10463985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blastic mantle cell lymphoma with a Burkitt translocation.
    Reddy K; Ansari-Lari M; Dipasquale B
    Leuk Lymphoma; 2008 Apr; 49(4):740-50. PubMed ID: 18398742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathologic characteristics of bone marrow for 
CD5 positive small B cell lymphoma].
    Peng S; Zhu F; You S; Gong M; Wen Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Apr; 41(4):374-9. PubMed ID: 27241147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia.
    Huang JC; Finn WG; Goolsby CL; Variakojis D; Peterson LC
    Am J Clin Pathol; 1999 Jan; 111(1):123-30. PubMed ID: 9894463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T lymphoblastic leukaemia with an unusual Burkitt lymphoma morphology--a case report.
    Pazur M; Jelić-Puskarić B; Planinc-Peraica A; Vrhovac R; Kardum-Skelin I; Jaksić B
    Coll Antropol; 2010 Jun; 34(2):675-8. PubMed ID: 20698152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemic phase of mantle cell lymphoma, blastoid variant.
    Singleton TP; Anderson MM; Ross CW; Schnitzer B
    Am J Clin Pathol; 1999 Apr; 111(4):495-500. PubMed ID: 10191769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.